Endovenous Stenting

Medicare covers endovenous stenting when performed with an FDA-approved (or valid IDE) stent for specified symptomatic, clinically significant venous obstructions or complications, including failed or suboptimal angioplasty (with defined residual stenosis or angioplasty complications), iliac/iliofemoral/iliocaval obstructions, post-thrombotic syndrome, SVC/IVC thrombosis, and several other listed conditions. Coverage is denied for uses not listed, asymptomatic/preventive stenting, stenting of popliteal/tibial veins, stents without FDA approval (except valid IDEs), venous stenosis ≤50% (or residual stenosis <30% post-angioplasty), and investigational indications such as routine IIH stenting; documentation of clinical findings, imaging, FDA status, and provider qualifications is required.

"Endovenous stent placement is covered as adjunct to angioplasty when angioplasty is judged by the physician to be suboptimal or failed due to unfavorable lesion morphology, including residual steno..."